Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02369523 · ClinicalTrials.gov registry record · Early Phase 1
Multimodal Pain Management Following Primary TKA
A Early Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 84
- Enrollment target
NCT02369523 is a Early Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 84 participants.
The verdict
NCT02369523, a Early Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 84 participants
- Enrollment target
Study Summary
The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compare quadriceps strength recovery over time and exploratory variables between the groups.
Interventions
- DRUG Bupivacaine
- DRUG Exparel
- DRUG Ropivacaine cocktail (PIC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02369523
The ClinicalTrials.gov registry entry for NCT02369523 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT02369523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02369523 about?
NCT02369523 is a clinical study titled "Multimodal Pain Management Following Primary TKA". The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compa...
What is the current status of trial NCT02369523?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 84 participants. The study started on 2014-09. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02369523?
The interventions under investigation include: Bupivacaine (DRUG), Exparel (DRUG), Ropivacaine cocktail (PIC) (DRUG).
Who is sponsoring clinical trial NCT02369523?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.